Publications
Publications
- Mitochondrial Quality Control in Alzheimer's Disease: Insights from Caenorhabditis elegans Models.; Antioxidants (Basel, Switzerland); Vol 13(11). 2024 Nov 01.
- Neuronal BAG3 attenuates tau hyperphosphorylation, synaptic dysfunction, and cognitive deficits induced by traumatic brain injury via the regulation of autophagy-lysosome pathway.; Acta neuropathologica; Vol 148(1), pp. 52. 2024 Oct 11.
- Tau phosphorylation suppresses oxidative stress-induced mitophagy via FKBP8 receptor modulation.; bioRxiv : the preprint server for biology. 2024 Jul 09.
- Stabilizing transglutaminase 2 in the open conformation results in reactive astrocytes being more neurosupportive.; bioRxiv : the preprint server for biology. 2024 Apr 19.
- Mitochondria-tau association promotes cognitive decline and hippocampal bioenergetic deficits during the aging.; Free radical biology & medicine. 2024 Mar 27.
- All-optical spatiotemporal mapping of ROS dynamics across mitochondrial microdomains in situ.; Nature communications; Vol 14(1), pp. 6036. 2023 Sep 27.
- Caspase-3 cleaved tau impairs mitochondrial function through the opening of the mitochondrial permeability transition pore.; Biochimica et biophysica acta. Molecular basis of disease. 2023 Sep 27.
- Deletion of Transglutaminase 2 from Mouse Astrocytes Significantly Improves Their Ability to Promote Neurite Outgrowth on an Inhibitory Matrix.; International journal of molecular sciences; Vol 24(7). 2023 Mar 23.
- Site-specific phosphorylation of tau impacts mitochondrial biology and response to stressors.; bioRxiv : the preprint server for biology. 2023 Feb 19.
- BAG3 regulates the specificity of the recognition of specific MAPT species by NBR1 and SQSTM1.; bioRxiv : the preprint server for biology. 2023 Feb 09.
- Deletion of transglutaminase 2 from astrocytes significantly improves their ability to promote neurite outgrowth on an inhibitory matrix.; bioRxiv : the preprint server for biology. 2023 Feb 06.
- BAG3 regulates the specificity of the recognition of specific MAPT species by NBR1 and SQSTM1.; Autophagy. 2023 Jan 30.
- Author Correction: All-optical spatiotemporal mapping of ROS dynamics across mitochondrial microdomains in situ.; Nature communications; Vol 14(1), pp. 8230. 2023 Jan 12.
- Site-specific phosphorylation of tau impacts mitochondrial function and response to stressors.; Journal of neurochemistry. 2023 Jan 03.
- Selective Disruption of Drp1-Independent Mitophagy and Mitolysosome Trafficking by an Alzheimer's Disease Relevant Tau Modification in a Novel C. elegans Model.; Genetics. 2022 Aug 02.
- Commentary: BAG3 as a mediator of endosome function and tau clearance.; Neuroscience. 2022 May 09.
- BAG3 Regulation of RAB35 Mediates the Endosomal Sorting Complexes Required for Transport/Endolysosome Pathway and Tau Clearance.; Biological psychiatry. 2021 Nov 10.
- Deletion or Inhibition of Astrocytic Transglutaminase 2 Promotes Functional Recovery after Spinal Cord Injury.; Cells; Vol 10(11). 2021 Oct 29.
- Tau Post-Translational Modifications: Potentiators of Selective Vulnerability in Sporadic Alzheimer's Disease.; Biology; Vol 10(10). 2021 Oct 15.
- Transglutaminase 2 as a therapeutic target for neurological conditions.; Expert opinion on therapeutic targets. 2021 Oct 05.
- The role of BAG3 in health and disease: A "Magic BAG of Tricks".; Journal of cellular biochemistry. 2021 May 14.
- A T231E Mutant that Mimics Pathologic Phosphorylation of Tau in Alzheimer's disease Causes Activation of the Mitochondrial Unfolded Protein Response in C. elegans touch neurons.; microPublication biology; Vol 2020. 2020 Sep 09.
- The Crosstalk Between Pathological Tau Phosphorylation and Mitochondrial Dysfunction as a Key to Understanding and Treating Alzheimer's Disease.; Molecular neurobiology. 2020 Aug 26.
- Tauopathy-associated tau modifications selectively impact neurodegeneration and mitophagy in a novel C. elegans single-copy transgenic model.; Molecular neurodegeneration; Vol 15(1). 2020 Jan 09.
- Presenilin 1 Regulates Membrane Homeostatic Pathways that are Dysregulated in Alzheimer's Disease.; Journal of Alzheimer's disease : JAD; Vol 77(3). 2020.
- The role of transglutaminase 2 in mediating glial cell function and pathophysiology in the central nervous system.; Analytical biochemistry. 2019 Dec 19.
- BAG3 and SYNPO (synaptopodin) facilitate phospho-MAPT/Tau degradation via autophagy in neuronal processes.; Autophagy. 2019 Feb 11.
- Tissue transglutaminase-mediated AT1 receptor sensitization underlies pro-inflammatory cytokine LIGHT-induced hypertension.; American journal of hypertension. 2019 Feb 02.
- A tau homeostasis signature is linked with the cellular and regional vulnerability of excitatory neurons to tau pathology.; Nature neuroscience; Vol 22(1). 2019 Jan.
- Tau Clearance Mechanisms.; Advances in experimental medicine and biology; Vol 1184. 2019.
- It's all about tau.; Progress in neurobiology. 2018 Dec 31.
- Nuclear transglutaminase 2 directly regulates expression of cathepsin S in rat cortical neurons.; The European journal of neuroscience. 2018 Sep 21.
- Transglutaminase 2: Friend or foe? The discordant role in neurons and astrocytes.; Journal of neuroscience research; Vol 96(7). 2018 Jul.
- Depletion of astrocytic transglutaminase 2 improves injury outcomes.; Molecular and cellular neurosciences. 2018 Jun 30.
- Depletion of transglutaminase 2 in neurons alters expression of extracellular matrix and signal transduction genes and compromises cell viability.; Molecular and cellular neurosciences; Vol 86. 2018 Jan.
- Nrf2 mediates the expression of BAG3 and autophagy cargo adaptor proteins and tau clearance in an age-dependent manner.; Neurobiology of aging; Vol 63. 2017 Dec 09.
- Subcellular localization patterns of transglutaminase 2 in astrocytes and neurons are differentially altered by hypoxia.; Neuroreport. 2017 Sep 27.
- Transglutaminase 2 Modulation of NF-κB Signaling in Astrocytes is Independent of its Ability to Mediate Astrocytic Viability in Ischemic Injury.; Brain research. 2017 May 15.
- The complex role of transglutaminase 2 in glioblastoma proliferation.; Neuro-oncology; Vol 19(2). 2017 Feb 01.
- Inhibition or ablation of transglutaminase 2 impairs astrocyte migration.; Biochemical and biophysical research communications; Vol 482(4). 2017 Jan 22.
- Assessing the degradation of tau in primary neurons: The role of autophagy.; Methods in cell biology; Vol 141. 2017.
- Endostatin and transglutaminase 2 are involved in fibrosis of the aging kidney.; Kidney international; Vol 89(6). 2016 Jun.
- Fisetin stimulates autophagic degradation of phosphorylated tau via the activation of TFEB and Nrf2 transcription factors.; Scientific reports; Vol 6. 2016 Apr 26.
- Mechanisms of tau and Aβ-induced excitotoxicity.; Brain research; Vol 1634. 2016 Mar 01.
- Epigallocatechin-3-gallate enhances clearance of phosphorylated tau in primary neurons.; Nutritional neuroscience; Vol 19(1). 2016.
- Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).; Autophagy; Vol 12(1). 2016.
- Tau facilitates Aβ-induced loss of mitochondrial membrane potential independent of cytosolic calcium fluxes in mouse cortical neurons.; Neuroscience letters; Vol 597. 2015 Jun 15.
- Autophagy in Alzheimer's disease.; Reviews in the neurosciences; Vol 26(4). 2015.
- BAG3 facilitates the clearance of endogenous tau in primary neurons.; Neurobiology of aging; Vol 36(1). 2015 Jan.
- NDP52 associates with phosphorylated tau in brains of an Alzheimer disease mouse model.; Biochemical and biophysical research communications; Vol 454(1). 2014 Nov 07.
- Phosphorylated tau potentiates Aβ-induced mitochondrial damage in mature neurons.; Neurobiology of disease; Vol 71. 2014 Nov.
- Sulforaphane induces autophagy through ERK activation in neuronal cells.; FEBS letters; Vol 588(17). 2014 Aug 25.
- Transglutaminase regulation of cell function.; Physiological reviews; Vol 94(2). 2014 Apr.
- Inhibition of transglutaminase 2, a novel target for pulmonary fibrosis, by two small electrophilic molecules.; American journal of respiratory cell and molecular biology; Vol 50(4). 2014 Apr.
- Nrf2 reduces levels of phosphorylated tau protein by inducing autophagy adaptor protein NDP52.; Nature communications; Vol 5. 2014.
- Mitochondrial permeability transition pore induces mitochondria injury in Huntington disease.; Molecular neurodegeneration; Vol 8. 2013 Dec 11.
- Transglutaminase and polyamination of tubulin: posttranslational modification for stabilizing axonal microtubules.; Neuron; Vol 78(1). 2013 Apr 10.
- Transglutaminase 2 facilitates or ameliorates HIF signaling and ischemic cell death depending on its conformation and localization.; Biochimica et biophysica acta; Vol 1833(1). 2013 Jan.
- Tau clearance mechanisms and their possible role in the pathogenesis of Alzheimer disease.; Frontiers in neurology; Vol 4. 2013.
- Impaired mitochondrial dynamics and Nrf2 signaling contribute to compromised responses to oxidative stress in striatal cells expressing full-length mutant huntingtin.; PloS one; Vol 8(3). 2013.
- Vena cava and aortic smooth muscle cells express transglutaminases 1 and 4 in addition to transglutaminase 2.; American journal of physiology. Heart and circulatory physiology; Vol 302(7). 2012 Apr 01.
- Guidelines for the use and interpretation of assays for monitoring autophagy.; Autophagy; Vol 8(4). 2012 Apr.
- Truncated tau and Aβ cooperatively impair mitochondria in primary neurons.; Neurobiology of aging; Vol 33(3). 2012 Mar.
- Complete transglutaminase 2 ablation results in reduced stroke volumes and astrocytes that exhibit increased survival in response to ischemia.; Neurobiology of disease; Vol 45(3). 2012 Mar.
- Transglutaminase 2: a molecular Swiss army knife.; Biochimica et biophysica acta; Vol 1823(2). 2012 Feb.
- Usp14 deficiency increases tau phosphorylation without altering tau degradation or causing tau-dependent deficits.; PloS one; Vol 7(10). 2012.
- Metabolic state determines sensitivity to cellular stress in Huntington disease: normalization by activation of PPARγ.; PloS one; Vol 7(1). 2012.
- Decreases in valosin-containing protein result in increased levels of tau phosphorylated at Ser262/356.; FEBS letters; Vol 585(21). 2011 Nov 04.
- Transglutaminase 2 and its role in pulmonary fibrosis.; American journal of respiratory and critical care medicine; Vol 184(6). 2011 Sep 15.
- The toxicity of tau in Alzheimer disease: turnover, targets and potential therapeutics.; Journal of cellular and molecular medicine; Vol 15(8). 2011 Aug.
- The application of permanent middle cerebral artery ligation in the mouse.; Journal of visualized experiments : JoVE. 2011 Jul 25.
- Influence of Methylobacterium on iron translocation in plants.; Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine; Vol 24(3). 2011 Jun.
- Suppression of autophagy and activation of glycogen synthase kinase 3beta facilitate the aggregate formation of tau.; The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology; Vol 15(2). 2011 Apr.
- Cytosolic guanine nucledotide binding deficient form of transglutaminase 2 (R580a) potentiates cell death in oxygen glucose deprivation.; PloS one; Vol 6(1). 2011 Jan 31.
- Split GFP complementation assay for quantitative measurement of tau aggregation in situ.; Methods in molecular biology (Clifton, N.J.); Vol 670. 2011.
- AES/GRG5: more than just a dominant-negative TLE/GRG family member.; Developmental dynamics : an official publication of the American Association of Anatomists; Vol 239(11). 2010 Nov.
- The role of tau kinases in Alzheimer's disease.; Current opinion in drug discovery & development; Vol 13(5). 2010 Sep.
- Transglutaminase 2 protects against ischemic stroke.; Neurobiology of disease; Vol 39(3). 2010 Sep.
- Differential modulation of TCF/LEF-1 activity by the soluble LRP6-ICD.; PloS one; Vol 5(7). 2010 Jul 28.
- A caspase cleaved form of tau is preferentially degraded through the autophagy pathway.; The Journal of biological chemistry; Vol 285(29). 2010 Jul 16.
- The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.; Journal of bioenergetics and biomembranes; Vol 42(3). 2010 Jun.
- Development of a rapid, high-efficiency, scalable refold for neurotrophin-4.; Biotechnology and applied biochemistry; Vol 56(1). 2010 May 19.
- Phosphorylation of PPP(S/T)P motif of the free LRP6 intracellular domain is not required to activate the Wnt/beta-catenin pathway and attenuate GSK3beta activity.; Journal of cellular biochemistry; Vol 108(4). 2009 Nov 01.
- Role of mitochondrial dysfunction in the pathogenesis of Huntington's disease.; Brain research bulletin; Vol 80(4-5). 2009 Oct 28.
- Caspase-cleaved tau expression induces mitochondrial dysfunction in immortalized cortical neurons: implications for the pathogenesis of Alzheimer disease.; The Journal of biological chemistry; Vol 284(28). 2009 Jul 10.
- Intracellular localization and conformational state of transglutaminase 2: implications for cell death.; PloS one; Vol 4(7). 2009 Jul 01.
- Increased expression of Bim contributes to the potentiation of serum deprivation-induced apoptotic cell death in Huntington's disease knock-in striatal cell line.; Neurological research; Vol 31(1). 2009 Feb.
- Immortalized cortical neurons expressing caspase-cleaved tau are sensitized to endoplasmic reticulum stress induced cell death.; Brain research; Vol 1234. 2008 Oct 09.
- Rosiglitazone treatment prevents mitochondrial dysfunction in mutant huntingtin-expressing cells: possible role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in the pathogenesis of Huntington disease.; The Journal of biological chemistry; Vol 283(37). 2008 Sep 12.
- Histone deacetylase 6 interacts with the microtubule-associated protein tau.; Journal of neurochemistry; Vol 106(5). 2008 Sep.
- Use of cyclohexanedimethanol as a nonflammable organic solvent for industrial scale reversed phase chromatography.; Journal of chromatography. A; Vol 1202(1). 2008 Aug 15.
- The last tangle of tau.; Journal of Alzheimer's disease : JAD; Vol 14(4). 2008 Aug.
- Transglutaminase 2 protects against ischemic insult, interacts with HIF1beta, and attenuates HIF1 signaling.; FASEB journal : official publication of the Federation of American Societies for Experimental Biology; Vol 22(8). 2008 Aug.
- New application of beta-galactosidase complementation to monitor tau self-association.; Journal of neurochemistry; Vol 106(4). 2008 Aug.
- Evaluation of refolding conditions for a human recombinant fusion cytokine protein, promegapoietin-1a.; Biotechnology and applied biochemistry; Vol 49(Pt 1). 2008 Jan.
- Split GFP complementation assay: a novel approach to quantitatively measure aggregation of tau in situ: effects of GSK3beta activation and caspase 3 cleavage.; Journal of neurochemistry; Vol 103(6). 2007 Dec.
- Mitochondrial-targeted active Akt protects SH-SY5Y neuroblastoma cells from staurosporine-induced apoptotic cell death.; Journal of cellular biochemistry; Vol 102(1). 2007 Sep 01.
- Activation of glycogen synthase kinase 3beta promotes the intermolecular association of tau. The use of fluorescence resonance energy transfer microscopy.; The Journal of biological chemistry; Vol 282(32). 2007 Aug 10.
- Type 2 transglutaminase differentially modulates striatal cell death in the presence of wild type or mutant huntingtin.; Journal of neurochemistry; Vol 102(1). 2007 Jul.
- Ubiquitin-proteasome system alterations in a striatal cell model of Huntington's disease.; Journal of neuroscience research; Vol 85(8). 2007 Jun.